 | • レポートコード：GIR-203B16442 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 静脈内抗体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の静脈内抗体の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の静脈内抗体の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 静脈内抗体市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・IgG、IgA、IgM、IgE、IgD 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の静脈内抗体市場の主要な市場プレーヤーは以下のとおりです。 ・Baxter International、CSL Limited、Biotest AG、OMRIX Biopharmaceuticals、Octapharma AG、Grifols, S.A、Guizhou Taibang Biological Products、Shanghai RAAS Blood Products、Hualan Biological Engineering、Kedrion S.p.A.、Beijing Tiantan Biological Products、China Biologic Products 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、静脈内抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な静脈内抗体メーカーの企業概要、2019年～2021年までの静脈内抗体の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な静脈内抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別静脈内抗体の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの静脈内抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での静脈内抗体市場予測を収録しています。 ・第12、13、14章では、静脈内抗体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Baxter International、CSL Limited、Biotest AG、OMRIX Biopharmaceuticals、Octapharma AG、Grifols, S.A、Guizhou Taibang Biological Products、Shanghai RAAS Blood Products、Hualan Biological Engineering、Kedrion S.p.A.、Beijing Tiantan Biological Products、China Biologic Products ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：IgG、IgA、IgM、IgE、IgD ・用途別分析2016年-2026年：病院、クリニック、その他 ・静脈内抗体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・静脈内抗体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・静脈内抗体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・静脈内抗体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・静脈内抗体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Intravenous Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Intravenous Antibodies size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Intravenous Antibodies market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Intravenous Antibodies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IgG
IgA
IgM
IgE
IgD
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Intravenous Antibodies market are listed below:
Baxter International
CSL Limited
Biotest AG
OMRIX Biopharmaceuticals
Octapharma AG
Grifols, S.A
Guizhou Taibang Biological Products
Shanghai RAAS Blood Products
Hualan Biological Engineering
Kedrion S.p.A.
Beijing Tiantan Biological Products
China Biologic Products
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Intravenous Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Antibodies, with price, sales, revenue and global market share of Intravenous Antibodies from 2019 to 2021.
Chapter 3, the Intravenous Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Intravenous Antibodies market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Intravenous Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Intravenous Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Antibodies Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Antibodies Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Intravenous Antibodies Market Size & Forecast
1.4.1 Global Intravenous Antibodies Sales in Value (2016-2026))
1.4.2 Global Intravenous Antibodies Sales in Volume (2016-2026)
1.4.3 Global Intravenous Antibodies Price by Type (2016-2026) & (US$/Unit)
1.5 Global Intravenous Antibodies Production Capacity Analysis
1.5.1 Global Intravenous Antibodies Total Production Capacity (2016-2026)
1.5.2 Global Intravenous Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Antibodies Market Drivers
1.6.2 Intravenous Antibodies Market Restraints
1.6.3 Intravenous Antibodies Trends Analysis
2 Manufacturers Profiles
2.1 Baxter International
2.1.1 Baxter International Details
2.1.2 Baxter International Major Business
2.1.3 Baxter International Intravenous Antibodies Product and Services
2.1.4 Baxter International Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CSL Limited
2.2.1 CSL Limited Details
2.2.2 CSL Limited Major Business
2.2.3 CSL Limited Intravenous Antibodies Product and Services
2.2.4 CSL Limited Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biotest AG
2.3.1 Biotest AG Details
2.3.2 Biotest AG Major Business
2.3.3 Biotest AG Intravenous Antibodies Product and Services
2.3.4 Biotest AG Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 OMRIX Biopharmaceuticals
2.4.1 OMRIX Biopharmaceuticals Details
2.4.2 OMRIX Biopharmaceuticals Major Business
2.4.3 OMRIX Biopharmaceuticals Intravenous Antibodies Product and Services
2.4.4 OMRIX Biopharmaceuticals Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Octapharma AG
2.5.1 Octapharma AG Details
2.5.2 Octapharma AG Major Business
2.5.3 Octapharma AG Intravenous Antibodies Product and Services
2.5.4 Octapharma AG Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Grifols, S.A
2.6.1 Grifols, S.A Details
2.6.2 Grifols, S.A Major Business
2.6.3 Grifols, S.A Intravenous Antibodies Product and Services
2.6.4 Grifols, S.A Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Guizhou Taibang Biological Products
2.7.1 Guizhou Taibang Biological Products Details
2.7.2 Guizhou Taibang Biological Products Major Business
2.7.3 Guizhou Taibang Biological Products Intravenous Antibodies Product and Services
2.7.4 Guizhou Taibang Biological Products Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Shanghai RAAS Blood Products
2.8.1 Shanghai RAAS Blood Products Details
2.8.2 Shanghai RAAS Blood Products Major Business
2.8.3 Shanghai RAAS Blood Products Intravenous Antibodies Product and Services
2.8.4 Shanghai RAAS Blood Products Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hualan Biological Engineering
2.9.1 Hualan Biological Engineering Details
2.9.2 Hualan Biological Engineering Major Business
2.9.3 Hualan Biological Engineering Intravenous Antibodies Product and Services
2.9.4 Hualan Biological Engineering Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kedrion S.p.A.
2.10.1 Kedrion S.p.A. Details
2.10.2 Kedrion S.p.A. Major Business
2.10.3 Kedrion S.p.A. Intravenous Antibodies Product and Services
2.10.4 Kedrion S.p.A. Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Beijing Tiantan Biological Products
2.11.1 Beijing Tiantan Biological Products Details
2.11.2 Beijing Tiantan Biological Products Major Business
2.11.3 Beijing Tiantan Biological Products Intravenous Antibodies Product and Services
2.11.4 Beijing Tiantan Biological Products Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 China Biologic Products
2.12.1 China Biologic Products Details
2.12.2 China Biologic Products Major Business
2.12.3 China Biologic Products Intravenous Antibodies Product and Services
2.12.4 China Biologic Products Intravenous Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Intravenous Antibodies Sales by Manufacturer
3.1 Global Intravenous Antibodies Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Intravenous Antibodies Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Intravenous Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Antibodies Manufacturer Market Share
3.4.2 Top 6 Intravenous Antibodies Manufacturer Market Share
3.5 Global Intravenous Antibodies Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Intravenous Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Antibodies Market Size by Region
4.1.1 Global Intravenous Antibodies Sales in Volume by Region (2016-2026)
4.1.2 Global Intravenous Antibodies Revenue by Region (2016-2026)
4.2 North America Intravenous Antibodies Revenue (2016-2026)
4.3 Europe Intravenous Antibodies Revenue (2016-2026)
4.4 Asia-Pacific Intravenous Antibodies Revenue (2016-2026)
4.5 South America Intravenous Antibodies Revenue (2016-2026)
4.6 Middle East and Africa Intravenous Antibodies Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Intravenous Antibodies Sales in Volume by Type (2016-2026)
5.2 Global Intravenous Antibodies Revenue by Type (2016-2026)
5.3 Global Intravenous Antibodies Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Intravenous Antibodies Sales in Volume by Application (2016-2026)
6.2 Global Intravenous Antibodies Revenue by Application (2016-2026)
6.3 Global Intravenous Antibodies Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Antibodies Sales by Type (2016-2026)
7.2 North America Intravenous Antibodies Sales by Application (2016-2026)
7.3 North America Intravenous Antibodies Market Size by Country
7.3.1 North America Intravenous Antibodies Sales in Volume by Country (2016-2026)
7.3.2 North America Intravenous Antibodies Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Antibodies Sales by Type (2016-2026)
8.2 Europe Intravenous Antibodies Sales by Application (2016-2026)
8.3 Europe Intravenous Antibodies Market Size by Country
8.3.1 Europe Intravenous Antibodies Sales in Volume by Country (2016-2026)
8.3.2 Europe Intravenous Antibodies Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Intravenous Antibodies Sales by Type (2016-2026)
9.2 Asia-Pacific Intravenous Antibodies Sales by Application (2016-2026)
9.3 Asia-Pacific Intravenous Antibodies Market Size by Region
9.3.1 Asia-Pacific Intravenous Antibodies Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Intravenous Antibodies Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Intravenous Antibodies Sales by Type (2016-2026)
10.2 South America Intravenous Antibodies Sales by Application (2016-2026)
10.3 South America Intravenous Antibodies Market Size by Country
10.3.1 South America Intravenous Antibodies Sales in Volume by Country (2016-2026)
10.3.2 South America Intravenous Antibodies Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Antibodies Sales by Type (2016-2026)
11.2 Middle East & Africa Intravenous Antibodies Sales by Application (2016-2026)
11.3 Middle East & Africa Intravenous Antibodies Market Size by Country
11.3.1 Middle East & Africa Intravenous Antibodies Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Intravenous Antibodies Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Intravenous Antibodies Typical Distributors
12.3 Intravenous Antibodies Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Intravenous Antibodies Revenue by Type, (USD Million), 2021-2026
Table 2. Global Intravenous Antibodies Revenue by Application, (USD Million), 2021-2026
Table 3. Baxter International Basic Information, Manufacturing Base and Competitors
Table 4. Baxter International Major Business
Table 5. Baxter International Intravenous Antibodies Product and Services
Table 6. Baxter International Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 8. CSL Limited Major Business
Table 9. CSL Limited Intravenous Antibodies Product and Services
Table 10. CSL Limited Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biotest AG Basic Information, Manufacturing Base and Competitors
Table 12. Biotest AG Major Business
Table 13. Biotest AG Intravenous Antibodies Product and Services
Table 14. Biotest AG Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. OMRIX Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. OMRIX Biopharmaceuticals Major Business
Table 17. OMRIX Biopharmaceuticals Intravenous Antibodies Product and Services
Table 18. OMRIX Biopharmaceuticals Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 20. Octapharma AG Major Business
Table 21. Octapharma AG Intravenous Antibodies Product and Services
Table 22. Octapharma AG Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Grifols, S.A Basic Information, Manufacturing Base and Competitors
Table 24. Grifols, S.A Major Business
Table 25. Grifols, S.A Intravenous Antibodies Product and Services
Table 26. Grifols, S.A Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Guizhou Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 28. Guizhou Taibang Biological Products Major Business
Table 29. Guizhou Taibang Biological Products Intravenous Antibodies Product and Services
Table 30. Guizhou Taibang Biological Products Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors
Table 32. Shanghai RAAS Blood Products Major Business
Table 33. Shanghai RAAS Blood Products Intravenous Antibodies Product and Services
Table 34. Shanghai RAAS Blood Products Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 36. Hualan Biological Engineering Major Business
Table 37. Hualan Biological Engineering Intravenous Antibodies Product and Services
Table 38. Hualan Biological Engineering Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kedrion S.p.A. Basic Information, Manufacturing Base and Competitors
Table 40. Kedrion S.p.A. Major Business
Table 41. Kedrion S.p.A. Intravenous Antibodies Product and Services
Table 42. Kedrion S.p.A. Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 44. Beijing Tiantan Biological Products Major Business
Table 45. Beijing Tiantan Biological Products Intravenous Antibodies Product and Services
Table 46. Beijing Tiantan Biological Products Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 48. China Biologic Products Major Business
Table 49. China Biologic Products Intravenous Antibodies Product and Services
Table 50. China Biologic Products Intravenous Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Intravenous Antibodies Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Intravenous Antibodies Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Intravenous Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Intravenous Antibodies Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Intravenous Antibodies Production Site of Key Manufacturer
Table 56. Intravenous Antibodies New Entrant and Capacity Expansion Plans
Table 57. Intravenous Antibodies Mergers & Acquisitions in the Past Five Years
Table 58. Global Intravenous Antibodies Sales by Region (2016-2021e) & (K Units)
Table 59. Global Intravenous Antibodies Sales by Region (2021-2026) & (K Units)
Table 60. Global Intravenous Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Intravenous Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 63. Global Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 64. Global Intravenous Antibodies Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Intravenous Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Intravenous Antibodies Price by Type (2016-2021e) & (US$/Unit)
Table 67. Global Intravenous Antibodies Price by Type (2021-2026) & (US$/Unit)
Table 68. Global Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 69. Global Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 70. Global Intravenous Antibodies Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Intravenous Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Intravenous Antibodies Price by Application (2016-2021e) & (US$/Unit)
Table 73. Global Intravenous Antibodies Price by Application (2021-2026) & (US$/Unit)
Table 74. North America Intravenous Antibodies Sales by Country (2016-2021e) & (K Units)
Table 75. North America Intravenous Antibodies Sales by Country (2021-2026) & (K Units)
Table 76. North America Intravenous Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Intravenous Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 79. North America Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 80. North America Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 81. North America Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 82. Europe Intravenous Antibodies Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Intravenous Antibodies Sales by Country (2021-2026) & (K Units)
Table 84. Europe Intravenous Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Intravenous Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 88. Europe Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Intravenous Antibodies Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Intravenous Antibodies Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Intravenous Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Intravenous Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 98. South America Intravenous Antibodies Sales by Country (2016-2021e) & (K Units)
Table 99. South America Intravenous Antibodies Sales by Country (2021-2026) & (K Units)
Table 100. South America Intravenous Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Intravenous Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 103. South America Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 104. South America Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 105. South America Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Intravenous Antibodies Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Intravenous Antibodies Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Intravenous Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Intravenous Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Intravenous Antibodies Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Intravenous Antibodies Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Intravenous Antibodies Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Intravenous Antibodies Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Intravenous Antibodies Typical Distributors
Table 117. Intravenous Antibodies Typical Customers
List of Figures
Figure 1. Intravenous Antibodies Picture
Figure 2. Global Intravenous Antibodies Sales Market Share by Type in 2020
Figure 3. IgG
Figure 4. IgA
Figure 5. IgM
Figure 6. IgE
Figure 7. IgD
Figure 8. Global Intravenous Antibodies Sales Market Share by Application in 2020
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Intravenous Antibodies Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Intravenous Antibodies Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Intravenous Antibodies Sales (2016-2026) & (K Units)
Figure 15. Global Intravenous Antibodies Price by Type (2016-2026) & (US$/Unit)
Figure 16. Global Intravenous Antibodies Production Capacity (2016-2026) & (K Units)
Figure 17. Global Intravenous Antibodies Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Intravenous Antibodies Market Drivers
Figure 19. Intravenous Antibodies Market Restraints
Figure 20. Intravenous Antibodies Market Trends
Figure 21. Global Intravenous Antibodies Sales Market Share by Manufacturer in 2020
Figure 22. Global Intravenous Antibodies Revenue Market Share by Manufacturer in 2020
Figure 23. Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Intravenous Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Intravenous Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Intravenous Antibodies Sales Market Share by Region (2016-2026)
Figure 27. Global Intravenous Antibodies Revenue Market Share by Region (2016-2026)
Figure 28. North America Intravenous Antibodies Revenue (2016-2026) & (USD Million)
Figure 29. Europe Intravenous Antibodies Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Intravenous Antibodies Revenue (2016-2026) & (USD Million)
Figure 31. South America Intravenous Antibodies Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Intravenous Antibodies Revenue (2016-2026) & (USD Million)
Figure 33. Global Intravenous Antibodies Sales Market Share by Type (2016-2026)
Figure 34. Global Intravenous Antibodies Revenue Market Share by Type (2016-2026)
Figure 35. Global Intravenous Antibodies Price by Type (2016-2026) & (US$/Unit)
Figure 36. Global Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 37. Global Intravenous Antibodies Revenue Market Share by Application (2016-2026)
Figure 38. Global Intravenous Antibodies Price by Application (2016-2026) & (US$/Unit)
Figure 39. North America Intravenous Antibodies Sales Market Share by Type (2016-2026)
Figure 40. North America Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 41. North America Intravenous Antibodies Sales Market Share by Country (2016-2026)
Figure 42. North America Intravenous Antibodies Revenue Market Share by Country (2016-2026)
Figure 43. United States Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Intravenous Antibodies Sales Market Share by Type (2016-2026)
Figure 47. Europe Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 48. Europe Intravenous Antibodies Sales Market Share by Country (2016-2026)
Figure 49. Europe Intravenous Antibodies Revenue Market Share by Country (2016-2026)
Figure 50. Germany Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Intravenous Antibodies Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Intravenous Antibodies Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Intravenous Antibodies Revenue Market Share by Region (2016-2026)
Figure 59. China Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Intravenous Antibodies Sales Market Share by Type (2016-2026)
Figure 66. South America Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 67. South America Intravenous Antibodies Sales Market Share by Country (2016-2026)
Figure 68. South America Intravenous Antibodies Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Intravenous Antibodies Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Intravenous Antibodies Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Intravenous Antibodies Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Intravenous Antibodies Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Intravenous Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
静脈内栄養補給のグローバル市場 2021年：企業別、地域別、種類・用途別 The Intravenous Feeding market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 小分子注射剤のグローバル市場 2021年：企業別、地域別、種類・用途別 The Small Molecule Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 使い捨て安全注射器のグローバル市場 2021年：企業別、地域別、種類・用途別 The Disposable Safety Syringes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 神経パッチのグローバル市場 2021年：企業別、地域別、種類・用途別 The Nerve Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- ヒドロキシプロゲステロンカプロエート注射のグローバル市場 2021年：企業別、地域別、種類・用途別 The Hydroxyprogesterone Caproate Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…